Ms Katherine Helm > Dechert LLP > New York, United States > Lawyer Profile

Dechert LLP
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
Katherine Helm photo

Work Department

Intellectual Property

Position

Partner

Career

Dr. Katherine A. (“Kassie”) Helm, Ph.D., represents clients in patent litigation and related intellectual property, antitrust, healthcare and international arbitration matters. Dr. Helm’s neuroscience background offers a unique perspective to innovator pharmaceutical, biotechnology and healthcare companies in all aspects of litigation, from pre-suit diligence through trial, appeal and full trials on remand.  She has represented life sciences companies in patent infringement, declaratory judgment, preliminary injunction and Hatch-Waxman actions, involving small and large molecules, as well as in pay-for-delay antitrust litigation, and in a variety of both federal and state complex commercial litigation and international arbitrations, involving joint ventures, licensing and drug development agreements.  Dr. Helm also has significant experience with concurrent Patent Office proceedings and global litigation including Inter Partes Reviews (IPRs), Post Grant Reviews (PGRs), Interferences and appeals, European Patent Office (EPO) Oppositions and appeals, as well as UK, French and other European patent revocation and infringement actions.

Education

  • Princeton University, A.B., 1999, cum laude, Sigma Xi
  • Johns Hopkins University, M.A., 2001
  • Johns Hopkins University, Ph.D., 2003, Full Scholarship, the Natural Sciences and Engineering Council of Canada
  • Fordham University School of Law, J.D., 2008, cum laude, Dean’s List, Parchomovsky-Siegelman Student Graduation Prize, Helen and Norman Burg Graduate Student Ethics Prize, Senior Articles Editor, Fordham Intellectual Property, Media & Entertainment Law Journal

Lawyer Rankings

United States > Healthcare > Life sciences

(Next Generation Partners)

Katherine HelmDechert LLP

Dechert LLP is well-placed to advise clients engaged in major cross-border transactions, including assisting with patent strategies tied to deals. On the contentious front, the firm’s litigators represent clients in patent disputes tied to a variety of drugs, and are also well versed in handling MDLs and class actions arising out of product liability claims. Boston-based patent specialist Andrea Reid advises biotech and pharmaceutical clients on the management of their IP portfolios, offering a deep understanding of the drug discovery and development processes and leading the practice alongside New York’s David Rosenthal, who advises life sciences-focused investors on IPOs, secondary offerings and licensing matters. Also based in New York, litigator Katherine Helm handles a broad spectrum of patent-related disputes, representing both plaintiffs and defendants in infringement suits and tackling commercial issues including breach of contract and antitrust litigations.

United States > Intellectual property > Patents: litigation (full coverage)

With broad technical expertise and cross-border capabilities, Dechert LLP represents clients in the life sciences industries before a variety of patent litigation venues. The group has a particularly strong appellate practice and also fields significant experience acting on behalf of petitioners and patent owners in Patent Trial and Appeal Board proceedings relating to pharmaceutical and biologic products. Trial lawyer Martin Black in Philadelphia leads the firm’s national IP litigation group, which also includes New York life sciences litigator Katherine Helm, who represents innovator pharmaceutical and biotech companies in both patent and patent-related litigation, and Amanda Antons in Chicago, who is highly experienced in ANDA litigation.